Dose Selection | Orasi Medical, Inc.

Accurate Dose Selection

Using Orasi Index™, drug developers can review MEG results to assess response to drug treatment and confidently select optimal dose. Orasi View can reveal electrophysiological features that support critical decision-making.

Orasi Index™ provides robust drug-effect relationship information.

Simulated dose response of OR914 as measured by the Orasi Index™

MEG is patient friendly

Image Courtesy of Elekta Neuromag
MEG passively measures the brain’s magnetic signature. No radiation or injections are needed. This simple and fast measurement improves clinical trial patient recruitment and retention. Learn more>>

Register to receive product updates:
Keep up-to-date about our rapidly growing database of drug and disease signatures as well as other relevant Orasi Medical developments.